Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Autor Inwards, D. J., Fishkin, P. A., LaPlant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S., Witzig, T. E.
Vydáno v Ann Oncol (2014)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Autor Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E
Vydáno v Ann Oncol (2019)

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Autor Witzig, T E, LaPlant, B, Habermann, T M, McPhail, E, Inwards, D J, Micallef, I N, Colgan, J P, Nowakowski, G S, Ansell, S M, Johnston, P B
Vydáno v Blood Cancer J (2017)

CD34(+) cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before...

Autor Holtan, S G, Hogan, W J, Elliott, M A, Ansell, S M, Inwards, D J, Porrata, L F, Johnston, P B, Micallef, I N, Lacy, M Q, Gastineau, D A, Litzow, M R
Vydáno v Bone Marrow Transplant (2010)

Widespread Use of Complementary and Alternative Medicine (CAM) among Non-Hodgkin Lymphoma (NHL) Survivors

Autor Osian, S. Rausch, Leal, A.D., Allmer, C., Maurer, M.J., Nowakowski, G., Inwards, D.J., Macon, W.R., Ehlers, S.L., Weiner, G.J., Habermann, T.M., Cerhan, J.R., Thompson, C.A.
Vydáno v Leuk Lymphoma (2014)

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

Autor Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N
Vydáno 2013

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas

Autor Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A
Vydáno 2014

Bowel perforation in intestinal lymphoma: incidence and clinical features

Autor Vaidya, R., Habermann, T. M., Donohue, J. H., Ristow, K. M., Maurer, M. J., Macon, W. R., Colgan, J. P., Inwards, D. J., Ansell, S. M., Porrata, L. F., Micallef, I. N., Johnston, P. B., Markovic, S. N., Thompson, C. A., Nowakowski, G. S., Witzig, T. E.
Vydáno 2013

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma

Autor Tracy, S I, Maurer, M J, Witzig, T E, Drake, M T, Ansell, S M, Nowakowski, G S, Thompson, C A, Inwards, D J, Johnston, P B, Micallef, I N, Allmer, C, Macon, W R, Weiner, G J, Slager, S L, Habermann, T M, Link, B K, Cerhan, J R
Vydáno v Blood Cancer J (2017)

A Phase II Study of (153)Sm-EDTMP and High Dose Melphalan as a Peripheral Blood Stem Cell Conditioning Regimen in Patients with Multiple Myeloma

Autor Dispenzieri, A., Wiseman, G.A., Lacy, M.Q., Hayman, S.R., Kumar, S.K., Buadi, F., Dingli, D., Laumann, K.M., Allred, J., Geyer, S.M., Litzow, M.R., Gastineau, D.A., Inwards, D.J., Micallef, I.N., Ansell, S.M., Porrata, L., Elliott, M.A., Johnston, P.B., Hogan, W.J., Gertz, M.A.
Vydáno 2010